Biofrontera Inc. (BFRI) › Cash & EquivalentsBiofrontera Inc. (BFRI) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $8.08M2021-12-31: $24.55M2022-12-31: $17.21M2023-12-31: $1.34M2024-12-31: $5.91M2025-12-31: $6.39M$6.39M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$6.39M+8.2%2026-03-19Balance as of period end2024-12-31$5.91M+339.7%2026-03-19Balance as of period end2023-12-31$1.34M-92.2%2025-03-20Balance as of period end2022-12-31$17.21M-29.9%2024-03-15Balance as of period end2021-12-31$24.55M+203.8%2023-03-13Balance as of period end2020-12-31$8.08M—2022-04-11Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)